capsaicin 0.35 MG/ML / lidocaine 40 MG/ML / trolamine salicylate 100 MG/ML Topical Solution

RxCUI
1987017
RxNorm name
capsaicin 0.35 MG/ML / lidocaine 40 MG/ML / trolamine salicylate 100 MG/ML Topical Solution
Display name
Capsaicin/Lidocaine/Trolamine salicylate (Topical)
Full name
capsaicin 0.35 MG/ML / lidocaine 40 MG/ML / trolamine salicylate 100 MG/ML Topical Solution
Term type
SCD
Status
Active
Strength
0.035-4-10%
Dose form
Sol
Route
Topical
Updated
2026-11-04 11:54:53

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122017
Active start
122017
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
capsaicin0.35 MG / 1 MLcapsaicincapsaicin
trolamine salicylate100 MG / 1 MLtrolamine salicylatetrolamine salicylate
lidocaine40 MG / 1 MLlidocainelidocaine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Solution316986

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
capsaicin1992
trolamine salicylate38866
lidocaine6387

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
71296001103rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCM02ABCapsaicin and similar agentsATC1-4capsaicin
ATCC05ADLocal anestheticsATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
ATCN01BXOther local anestheticsATC1-4capsaicin
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
MEDRTD002211CapsaicinCHEMhas_ingredientcapsaicin
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD012459SalicylatesCHEMhas_ingredienttrolamine salicylate
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD003929Diabetic NeuropathiesDISEASEmay_treatcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withcapsaicin
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD006562Herpes ZosterDISEASEmay_treatcapsaicin
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009437NeuralgiaDISEASEmay_treatcapsaicin
MEDRTD010146PainDISEASEmay_preventtrolamine salicylate
MEDRTD010146PainDISEASEmay_preventcapsaicin
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treattrolamine salicylate
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moatrolamine salicylate
MEDRTN0000000105Neurotransmitter Transporter InteractionsMOAhas_moacapsaicin
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_petrolamine salicylate
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pecapsaicin
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.35 MG/ML / 40 MG/ML / 100 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable Synonymcapsaicin 0.035 % / lidocaine 4 % / trolamine salicylate 10 % Topical Solution
SOURCESSourceGold Standard Alchemy
SOURCESSourceNational Drug Data File Plus Source Vocabulary